Publication:
Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir

1

Issued Date

2008-01-01

Resource Type

Letter

ISSN

15254135

DOI

10.1097/QAI.0b013e318157b0da

Other identifier(s)

2-s2.0-39049117418

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Journal of Acquired Immune Deficiency Syndromes. Vol.47, No.1 (2008), 127-129

Suggested Citation

Weerawat Manosuthi, Somnuek Sungkanuparph, Kiat Ruxrungtham, Wisit Prasithsirikul, Chatiya Athichathanabadi, Woraphot Tantisiriwat, Chureeratana Bowonwatanuwong, Nopphanath Chumpathat, Achara Chaovavanich Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir. Journal of Acquired Immune Deficiency Syndromes. Vol.47, No.1 (2008), 127-129. doi:10.1097/QAI.0b013e318157b0da Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/19384

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir

Author(s)

Weerawat Manosuthi
 Somnuek Sungkanuparph
 Kiat Ruxrungtham
 Wisit Prasithsirikul
 Chatiya Athichathanabadi
 Woraphot Tantisiriwat
 Chureeratana Bowonwatanuwong
 Nopphanath Chumpathat
 Achara Chaovavanich

Other Contributor(s)

Thailand Ministry of Public Health
 Mahidol University
 The HIV Netherlands Australia Thailand Research Collaboration
 Srinakharinwirot University
 Chonburi Regional Hospital

Keyword(s)

Immunology and Microbiology

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/19384

Collections

Scopus 2006-2010